BRPI1015447A2 - soluções pediátricas compreendendo um bloqueador beta - Google Patents

soluções pediátricas compreendendo um bloqueador beta

Info

Publication number: BRPI1015447A2
Authority: BR; Brazil
Prior art keywords: pediatric; solutions; beta blocker; blocker; beta
Prior art date: 2009-04-21

Application number

BRPI1015447A

Other languages

English (en)

Inventor

Chaumont Christine

Cordoliani Jean-François

Leverd Elie

Muguet Valérie

Original Assignee

Fabre Pierre Dermo Cosmetique

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-04-21

Filing date

2010-04-12

Publication date

2016-04-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40940328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1015447(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-04-12 Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique

2016-04-19 Publication of BRPI1015447A2 publication Critical patent/BRPI1015447A2/pt

2017-10-03 Publication of BRPI1015447A8 publication Critical patent/BRPI1015447A8/pt

2020-01-28 Publication of BRPI1015447B1 publication Critical patent/BRPI1015447B1/pt

Links

239000002876 beta blocker Substances 0.000 title 1
229940097320 beta blocking agent Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Inorganic Chemistry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Hematology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Seasonings (AREA)
Saccharide Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

BRPI1015447A 2009-04-21 2010-04-12 soluções pediátricas compreendendo um bloqueador beta BRPI1015447B1 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP09290298A EP2246044A1 (en)	2009-04-21	2009-04-21	Paediatric solutions comprising a beta-blocker
PCT/IB2010/051573 WO2010122442A1 (en)	2009-04-21	2010-04-12	Paediatric solutions comprising a beta-blocker

Publications (3)

Publication Number	Publication Date
BRPI1015447A2 true BRPI1015447A2 (pt)	2016-04-19
BRPI1015447A8 BRPI1015447A8 (pt)	2017-10-03
BRPI1015447B1 BRPI1015447B1 (pt)	2020-01-28

Family

ID=40940328

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1015447A BRPI1015447B1 (pt)	2009-04-21	2010-04-12	soluções pediátricas compreendendo um bloqueador beta

Country Status (32)

Country	Link
US (2)	US20120035270A1 (pt)
EP (4)	EP2246044A1 (pt)
JP (1)	JP5695029B2 (pt)
KR (1)	KR101713866B1 (pt)
CN (1)	CN102405041A (pt)
AR (2)	AR076338A1 (pt)
AU (1)	AU2010240551B2 (pt)
BR (1)	BRPI1015447B1 (pt)
CA (1)	CA2755175C (pt)
CL (1)	CL2011002634A1 (pt)
CO (1)	CO6410278A2 (pt)
CY (2)	CY1119390T1 (pt)
DK (2)	DK2497461T4 (pt)
ES (2)	ES2685178T5 (pt)
GE (1)	GEP20146087B (pt)
HR (2)	HRP20170610T4 (pt)
HU (2)	HUE039937T2 (pt)
IL (1)	IL214674A (pt)
LT (2)	LT2421504T (pt)
MA (1)	MA33003B1 (pt)
MX (1)	MX337463B (pt)
NZ (1)	NZ594592A (pt)
PL (2)	PL2497461T5 (pt)
PT (2)	PT2497461T (pt)
RS (2)	RS57668B2 (pt)
RU (1)	RU2011139233A (pt)
SG (1)	SG172960A1 (pt)
SI (2)	SI2497461T2 (pt)
TN (1)	TN2011000350A1 (pt)
TW (1)	TWI429459B (pt)
UA (1)	UA107570C2 (pt)
WO (1)	WO2010122442A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2246044A1 (en)	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Paediatric solutions comprising a beta-blocker
CN103501775A (zh) *	2011-03-04	2014-01-08	格吕伦塔尔有限公司	他喷他多的胃肠外给药
MX388963B (es)	2011-03-04	2025-03-20	Gruenenthal Gmbh	Formulacion farmaceutica acuosa de tapentadol para administracion oral
JP2019142972A (ja) *	2011-03-04	2019-08-29	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	タペンタドールの非経口的投与
US9724297B2 (en)	2014-04-01	2017-08-08	Arbor Pharmaceuticals, Inc.	Sotalol compositions and uses of the same
PE20171651A1 (es)	2015-03-27	2017-11-13	Gruenenthal Chemie	Formulacion estable para administracion parenteral de tapentadol
EP3515412B1 (en)	2016-09-23	2025-04-23	Grünenthal GmbH	Stable formulation for parenteral administration of tapentadol
CN108261411B (zh) *	2016-12-30	2021-04-30	武汉科福新药有限责任公司	用于婴幼儿血管瘤治疗的口腔膜剂及其制备方法
CN107320467A (zh) *	2017-07-21	2017-11-07	江苏云阳集团药业有限公司	一种盐酸普萘洛尔药用组合物及其制备方法
CN108299279B (zh) *	2018-02-09	2021-03-23	北京梅尔森医药技术开发有限公司	取代芳基胺醇化合物及其制备方法和用途
US11547123B2 (en) *	2019-08-16	2023-01-10	The Folger Coffee Company	Methods for reducing negative flavor attributes in coffee and compositions therefrom
US10610502B1 (en) *	2019-08-30	2020-04-07	Metacel Pharmaceuticals, LLC	Oral baclofen solutions
JPWO2022071481A1 (pt)	2020-09-30	2022-04-07
CN116407495A (zh) *	2023-03-09	2023-07-11	北京梅尔森医药技术开发有限公司	一种阿替洛尔口服溶液及其制备方法和应用
GB2628566A (en)	2023-03-29	2024-10-02	Novumgen Ltd	An orally rapidly disintegrating tablet of propranolol and its process of preparation
WO2025068937A1 (en)	2023-09-30	2025-04-03	Liqmeds Worldwide Limited	An oral liquid formulation of metoprolol
CN118021718B (zh) *	2024-04-12	2024-07-02	成都瑞尔医药科技有限公司	一种盐酸普罗帕酮注射液及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4600708A (en)	1985-07-19	1986-07-15	American Home Products Corporation	Propranolol hydrochloride liquid formulations
HU209251B (en)	1992-03-13	1994-04-28	Synepos Ag	Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
EP0732064B1 (en)	1995-03-15	2001-06-06	Kao Corporation	Use of a bitterness relieving agent
JPH1025253A (ja) *	1996-07-12	1998-01-27	Kao Corp	苦味低減化剤及び苦味低減化法
JPH11349492A (ja) *	1998-06-03	1999-12-21	Yamanouchi Pharmaceut Co Ltd	苦味を低減した経口用医薬組成物および苦味低減化方法
JP2001342151A (ja) *	2000-03-31	2001-12-11	Eisai Co Ltd	甘味を有する薬剤組成物
DE60213592T2 (de) *	2001-05-25	2007-08-09	Warner-Lambert Co. Llc	Flüssige pharmazeutische zusammensetzung
EP1543831A1 (en) *	2003-12-18	2005-06-22	Pfizer GmbH Arzneimittelwerk Gödecke	Pregabalin composition
WO2006093493A1 (en) *	2005-02-25	2006-09-08	Biomarin Pharmaceutical Inc.	Room temperature stable aqueous liquid pharmaceutical composition
EP1888030A1 (en) *	2005-05-25	2008-02-20	Janssen Pharmaceutica N.V.	Pediatric formulation of topiramate
DE102006020604A1 (de) *	2006-05-02	2007-11-08	Bayer Healthcare Ag	Flüssige Arzneimittelformulierung
EP2050441A1 (en)	2007-10-19	2009-04-22	Université Victor Segalen Bordeaux 2	Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
EP2268282B1 (en) *	2008-04-25	2014-10-29	Apotex Technologies Inc.	Liquid formulation for deferiprone with palatable taste
EP2246044A1 (en)	2009-04-21	2010-11-03	Pierre Fabre Dermo-Cosmétique	Paediatric solutions comprising a beta-blocker

2009
- 2009-04-21 EP EP09290298A patent/EP2246044A1/en not_active Withdrawn
2010
- 2010-04-12 DK DK12155472.9T patent/DK2497461T4/da active
- 2010-04-12 BR BRPI1015447A patent/BRPI1015447B1/pt active IP Right Grant
- 2010-04-12 RS RS20181036A patent/RS57668B2/sr unknown
- 2010-04-12 AU AU2010240551A patent/AU2010240551B2/en active Active
- 2010-04-12 SG SG2011050663A patent/SG172960A1/en unknown
- 2010-04-12 ES ES12155472T patent/ES2685178T5/es active Active
- 2010-04-12 PL PL12155472T patent/PL2497461T5/pl unknown
- 2010-04-12 PT PT12155472T patent/PT2497461T/pt unknown
- 2010-04-12 NZ NZ594592A patent/NZ594592A/xx unknown
- 2010-04-12 CN CN2010800174060A patent/CN102405041A/zh active Pending
- 2010-04-12 HR HRP20170610TT patent/HRP20170610T4/hr unknown
- 2010-04-12 WO PCT/IB2010/051573 patent/WO2010122442A1/en not_active Ceased
- 2010-04-12 HU HUE12155472A patent/HUE039937T2/hu unknown
- 2010-04-12 PL PL10717263.7T patent/PL2421504T5/pl unknown
- 2010-04-12 EP EP10717263.7A patent/EP2421504B2/en active Active
- 2010-04-12 KR KR1020117024721A patent/KR101713866B1/ko active Active
- 2010-04-12 PT PT107172637T patent/PT2421504T/pt unknown
- 2010-04-12 RS RS20170358A patent/RS55862B2/sr unknown
- 2010-04-12 MX MX2011010766A patent/MX337463B/es active IP Right Grant
- 2010-04-12 HU HUE10717263A patent/HUE034581T2/en unknown
- 2010-04-12 RU RU2011139233/15A patent/RU2011139233A/ru unknown
- 2010-04-12 US US13/265,739 patent/US20120035270A1/en not_active Abandoned
- 2010-04-12 EP EP18174428.5A patent/EP3384899A1/en active Pending
- 2010-04-12 SI SI201031741T patent/SI2497461T2/sl unknown
- 2010-04-12 SI SI201031439A patent/SI2421504T1/sl unknown
- 2010-04-12 EP EP12155472.9A patent/EP2497461B2/en active Active
- 2010-04-12 CA CA2755175A patent/CA2755175C/en active Active
- 2010-04-12 DK DK10717263.7T patent/DK2421504T4/da active
- 2010-04-12 MA MA34064A patent/MA33003B1/fr unknown
- 2010-04-12 JP JP2012506607A patent/JP5695029B2/ja active Active
- 2010-04-12 LT LTEP10717263.7T patent/LT2421504T/lt unknown
- 2010-04-12 GE GEAP201012468A patent/GEP20146087B/en unknown
- 2010-04-12 ES ES10717263T patent/ES2623936T5/es active Active
- 2010-04-12 LT LTEP12155472.9T patent/LT2497461T/lt unknown
- 2010-04-20 AR ARP100101299A patent/AR076338A1/es not_active Application Discontinuation
- 2010-04-20 TW TW099112270A patent/TWI429459B/zh active
- 2010-12-04 UA UAA201112317A patent/UA107570C2/ru unknown
2011
- 2011-07-15 TN TN2011000350A patent/TN2011000350A1/fr unknown
- 2011-07-28 CO CO11095137A patent/CO6410278A2/es not_active Application Discontinuation
- 2011-08-15 IL IL214674A patent/IL214674A/en active IP Right Grant
- 2011-10-21 CL CL2011002634A patent/CL2011002634A1/es unknown
2014
- 2014-12-01 US US14/556,861 patent/US20150087719A1/en not_active Abandoned
2017
- 2017-05-31 CY CY20171100562T patent/CY1119390T1/el unknown
2018
- 2018-09-03 HR HRP20181408TT patent/HRP20181408T4/hr unknown
- 2018-09-07 CY CY181100939T patent/CY1120667T1/el unknown
2019
- 2019-07-25 AR ARP190102095A patent/AR117621A2/es unknown

Also Published As

Publication number	Publication date
EP3384899A1 (en)	2018-10-10
ES2623936T3 (es)	2017-07-12
WO2010122442A1 (en)	2010-10-28
PT2421504T (pt)	2017-06-16
DK2497461T3 (en)	2018-09-03
IL214674A (en)	2017-01-31
TN2011000350A1 (en)	2013-03-27
CY1120667T1 (el)	2019-12-11
MX337463B (es)	2016-03-07
HRP20181408T1 (hr)	2018-11-02
RU2011139233A (ru)	2013-05-27
PL2497461T5 (pl)	2022-06-27
EP2497461B2 (en)	2021-12-15
IL214674A0 (en)	2011-09-27
RS57668B1 (sr)	2018-11-30
CA2755175C (en)	2018-01-02
AR117621A2 (es)	2021-08-18
BRPI1015447A8 (pt)	2017-10-03
UA107570C2 (xx)	2015-01-26
MX2011010766A (es)	2011-10-21
NZ594592A (en)	2013-11-29
LT2421504T (lt)	2017-06-12
AR076338A1 (es)	2011-06-01
SI2497461T2 (sl)	2022-04-29
EP2421504A1 (en)	2012-02-29
AU2010240551B2 (en)	2015-07-16
DK2421504T3 (en)	2017-05-01
JP5695029B2 (ja)	2015-04-01
US20150087719A1 (en)	2015-03-26
CY1119390T1 (el)	2018-02-14
HRP20170610T1 (hr)	2017-07-28
EP2246044A1 (en)	2010-11-03
TWI429459B (zh)	2014-03-11
PT2497461T (pt)	2018-10-23
CN102405041A (zh)	2012-04-04
EP2421504B1 (en)	2017-03-08
ES2685178T5 (es)	2022-04-13
RS55862B2 (sr)	2022-12-30
SG172960A1 (en)	2011-08-29
CO6410278A2 (es)	2012-03-30
ES2685178T3 (es)	2018-10-05
EP2421504B2 (en)	2022-08-10
LT2497461T (lt)	2018-10-10
HUE039937T2 (hu)	2019-02-28
BRPI1015447B1 (pt)	2020-01-28
TW201039862A (en)	2010-11-16
SI2421504T1 (sl)	2017-06-30
CA2755175A1 (en)	2010-10-28
HRP20181408T4 (hr)	2022-03-04
DK2421504T4 (da)	2022-11-14
DK2497461T4 (da)	2022-02-14
RS55862B1 (sr)	2017-08-31
SI2497461T1 (sl)	2018-10-30
PL2421504T3 (pl)	2017-08-31
RS57668B2 (sr)	2022-03-31
US20120035270A1 (en)	2012-02-09
HRP20170610T4 (hr)	2022-12-09
AU2010240551A1 (en)	2011-08-04
GEP20146087B (en)	2014-05-13
EP2497461A3 (en)	2014-01-01
EP2497461B1 (en)	2018-06-20
ES2623936T5 (es)	2022-11-28
KR20120015305A (ko)	2012-02-21
JP2012524773A (ja)	2012-10-18
PL2497461T3 (pl)	2018-12-31
KR101713866B1 (ko)	2017-03-09
EP2497461A2 (en)	2012-09-12
CL2011002634A1 (es)	2012-06-08
PL2421504T5 (pl)	2023-01-02
MA33003B1 (fr)	2012-01-02
HUE034581T2 (en)	2018-02-28

Legal Events

Date	Code	Title	Description
2017-10-03	B25A	Requested transfer of rights approved	Owner name: PIERRE FABRE DERMATOLOGIE (FR)
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-07-17	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2019-01-08	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-05-21	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2019-10-08	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-11-26	B06I	Publication of requirement cancelled [chapter 6.9 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 6.1 NA RPI NO 2544 DE 08/10/2019 POR TER SIDO INDEVIDA.
2019-12-10	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-01-28	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/04/2010, OBSERVADAS AS CONDICOES LEGAIS.
2024-04-09	B25A	Requested transfer of rights approved	Owner name: PIERRE FABRE MEDICAMENT (FR)

Publication	Publication Date	Title
BRPI1015447A2 (pt)	2016-04-19	soluções pediátricas compreendendo um bloqueador beta
CY2017026I1 (el)	2017-11-14	Τετρακυκλικη ενωση
NL301213I2 (nl)	2023-12-14	eptacog beta
DK2289304T3 (da)	2013-12-02	Høstmaskine
EP2515984A4 (en)	2015-04-01	INTERFACE
DE102009037898A8 (de)	2011-06-01	Greifeinrichtung
BRPI1013639A2 (pt)	2016-04-19	medicamentos antidiabéticos
EP2409724A4 (en)	2014-03-12	Medical guide wire
EP2406768A4 (en)	2014-08-20	DISTRIBUTION BACKBONE
EP2374250A4 (en)	2012-10-24	LOAD BALANCING
FR2958801B1 (fr)	2012-05-25	Biopile a glucose
BRPI1013868A2 (pt)	2016-04-05	composto diaciletilenodiamina
EP2436488A4 (en)	2015-04-22	TONG
DK2490708T3 (da)	2013-04-15	Stabiliserede glucagon-opløsninger
EP2499707A4 (en)	2014-01-22	INTERFACE
DK2429882T3 (da)	2013-11-25	Forbindelsesanordning
EP2378292A4 (en)	2014-01-15	Autoanalyzer
DK2434863T3 (da)	2013-07-08	Vikleindretning
EP2502865A4 (en)	2013-10-02	coil winder
IT1395049B1 (it)	2012-09-05	Gruppo di infusione
IT1394469B1 (it)	2012-07-05	Meccanismi a biellette per chiusura a tapparella blindata
FR2946558B3 (fr)	2011-05-20	Agrafeuse a reduction d?effort
DE102009035147A8 (de)	2011-06-01	Flattergetriebe
IT1395044B1 (it)	2012-09-05	Apritoio a flusso assiale
ZA201202528B (en)	2013-01-30	Optical structure with a flat apex